EMA accepts MAA for Dong-A ST’s Stelara biosimilar, DMB-3115

Dong-A ST, the South Korean pharmaceutical company, has received confirmation from the European Medicine Agency (EMA) of the acceptance of their Marketing Authorization Application (MAA) ... Read More